Creating more effective, efficient, and secure healthcare to improve health outcomes globally is one of the world’s most important challenges today. Oracle's acquisition of Cerner will transform healthcare delivery by providing a new generation of modern, secure healthcare information systems. Better insights enable governments to respond faster to public health crises, help caregivers make informed treatment decisions, and deliver better patient outcomes.
Larry Ellison is chairman of Oracle Corporation and chief technology officer. He founded the company in 1977 and served as CEO until September 2014. He also races sailboats, flies planes, and plays tennis and guitar.
Tony Blair served as prime minister of Great Britain and Northern Ireland from 1997 to 2007, the only Labour leader in the party’s 100-year history to win three consecutive general elections.
During his time in office, the UK economy enjoyed record growth. His government made major improvements in Britain’s public services, particularly healthcare and education, through a program of investment and reform. Britain’s first-ever statutory minimum wage was introduced. The prime minister led the successful London 2012 Olympics bid and oversaw the peace process for Northern Ireland. He introduced the first elected mayor for London, the Scottish Parliament, Welsh Assembly, and Northern Ireland Assembly.
He was a staunch advocate of an interventionist foreign policy, in particular in Kosovo, Sierra Leone, Afghanistan, and Iraq. He tripled the UK’s aid program for Africa and introduced the first environmental program in the UK to combat climate change.
Since leaving office, Tony has spent most of his time working on three areas: supporting governments to deliver effectively for their people, working for peace in the Middle East, and countering extremism. He has established the Tony Blair Institute for Global Change to work on some of the most difficult challenges in the world today, including how the center ground of politics renews itself with practical policy solutions.
Mike Sicilia is executive vice president of Oracle Industries. In his previous role he was the senior vice president and general manager of Oracle Construction and Engineering, the business unit that focuses on enterprise project and portfolio management solutions for asset-intensive industries. Mike joined Oracle as part of its 2008 acquisition of Primavera Systems and was named senior vice president and general manager of that business unit in 2011. After Oracle’s 2016 acquisition of Textura, a leading provider of construction contracts and payment management cloud services, the Oracle Primavera global business unit was renamed Oracle Construction and Engineering.
Prior to joining Oracle, Mike worked at Primavera Systems, joining the development department in 1993, where he worked as a programmer on the company’s flagship products. He was named Primavera’s chief technology officer in 2006. As CTO, he set the technology direction for products and managed the global development team. Mike also led the technical and product presentations and due diligence team that worked through the Oracle acquisition. He graduated from Saint Joseph’s University in Pennsylvania with a BS in computer science.
Stephanie Trunzo is senior vice president and general manager for Oracle Health. Her diversely skilled team is responsible for the strategy, design, build, and global go-to-market execution of Oracle’s healthcare industry solutions.
While Stephanie is a tech geek across cloud, AI, and emerging tech, she is also a storyteller with a commitment to usability and design thinking. This is reflected in the mission of Oracle Health to create human-centric healthcare experiences powered by data. Through this mission, Stephanie hopes to reimagine healthcare technology services and infrastructure using the power of Oracle’s industry-leading data and cloud solutions.
Prior to joining Oracle Health, Stephanie applied her digital and experience disciplines to create and deploy Oracle’s global, value-based approach for multicloud, hybrid customer strategies. Stephanie joined Oracle from IBM where she was the Global Head of IBM Cloud Garage, a network of more than a dozen innovation hubs purpose-built to meld industry practices, startup culture, and IBM's expertise. Prior to that, she founded and led her digital transformation start-up through a public acquisition to Globant.
Stephanie was affectionately dubbed “the prototype” for the Chief Digital Officer role by the CDO Club. She is an active advisor, giving back to non-profits and early start-ups, including TechGirlz, WomenNC, and InsureLife. Her writing can be found in publications such as Fast Company, Forbes, and Huffington Post.
Steve Miranda is executive vice president of Oracle Fusion Cloud Applications product development. He is responsible for leading all aspects of product strategy, product development, and product delivery for the entire portfolio of Oracle Applications and related services. Steve’s primary focus is on delivering the industry’s most complete, proven, and innovative set of cloud solutions encompassing enterprise resource planning; supply chain, human capital, and enterprise performance management; and advertising and customer experience applications.
Steve joined Oracle in 1992 and has held a variety of leadership positions within the development organization. In 2007, he was asked to lead the engineering of Oracle’s next-generation suite of software applications, Oracle Fusion Applications. Under his leadership, Oracle has delivered on its promise to help applications customers innovate and remain competitive while leveraging their existing IT investments and increasing the value of those investments with new Oracle products and services.
Prior to Oracle, Miranda worked at GE Aerospace. He holds degrees in mathematics and computational sciences from Stanford University.
As chief product officer, Brenna Quinn has accountability for Cerner’s product portfolio of offerings for the provider enterprise market. Brenna is responsible for the strategy, product advancement, and overall market success of Cerner’s clinical, revenue cycle, consumer, and real time health solutions. She brings more than 30 years of health information technology experience with Shared Medical Services, Siemens, and Cerner. Brenna joined Cerner in 2015 with the Siemens Health Services acquisition. She is responsible for global leadership of Cerner’s strategy, product management, and solution advisory teams aligned to these solutions.
Brenna has previously held executive leadership roles over solution development, global marketing, and professional services and, most recently, executive leadership for Cerner’s revenue cycle business division. During her time with Cerner and Siemens, Brenna’s key leadership roles allowed her to develop strong client-partner relationships and gain experience driving initiatives across all areas of internal operations.
Brenna is a graduate of Villanova University with a Bachelor of Arts. She has attended numerous executive management courses including the European School of Management and Technology. Brenna is a member of Health Information and Management Systems Society (HIMSS), American Congress of Health Care Executives (ACHE), and Health Financial Management Association (HFMA). She is also on the board of directors for the Chester County Economic Development Council and Downingtown STEM Academy.
As Cerner’s president and CEO, David Feinberg focuses on delivering tools and technology that help caregivers optimize the health of their patients and communities.
As a pediatric psychiatrist, David built his early career around helping children and families. He served as president and CEO of both UCLA Health and Geisinger Health prior to assuming leadership of Google Health in early 2019.
His work at UCLA provided David a clear view of how patient satisfaction translates to clinical success. His focus on the patient experience increased UCLA’s patient satisfaction scores from the 28th to the 99th percentile.
At Geisinger, David led a complex turnaround that made Geisinger one of the nation’s most innovative healthcare providers, including a first-of-its kind clinical program that made DNA sequencing a routine part of patient care. David also guided Geisinger’s transition to value-based care using Cerner’s population health platform, HealtheIntent, integrated with a non-Cerner EMR.
At Google, David leveraged Google’s technology, talent, and search capabilities to tackle healthcare’s most important challenges. Under David’s leadership, Google was at the forefront of using AI and mobile platforms to improve healthcare and—in partnership with Ascension Health—produced Care Studio, a tool that organizes patient records for healthcare clinicians at the point of care.
David began his career at UCLA, researching and publishing in the areas of addiction and attention deficit hyperactivity disorder. He took on additional leadership responsibilities, including becoming the medical director of the Resnick Neuropsychiatric Hospital. By implementing rigorous service metrics and patient satisfaction measures and completing a financial turnaround, UCLA’s neuropsychiatric hospital is now considered the premier psychiatric hospital in the western United States.
David earned his MD from Chicago Medical School in 1989, finishing at the top of his class and is a member of the Alpha Omega Alpha Medical Honor Society. He also holds an economics degree from the University of California at Berkeley and an MBA from Pepperdine University.
David Walliker is fellow of the British Computer Society and provides leadership and accountability for digital, data, and strategy for Oxford University Hospitals and its relationships with external partners, acting as NHS Foundation Trust lead on developing partnerships.
Kevin Jarrold has been the CIO for Imperial College Healthcare, NHS Trust (ICHT) since 2011. Prior to that he was the CIO for NHS London, the strategic health authority for the capital. In 2016, he combined the role at Imperial with the additional role of CIO for Chelsea and Westminster Hospital, NHS Foundation Trust when the decision was made to extend the use of the ICHT Cerner electronic patient record to Chelwest. This led to both ICHT and Chelwest being recognised as part of the NHS Global Digital Exemplar program. Kevin has now taken on the additional role of CIO for the North West London Clinical Commissioning Group and interim CIO for the North West London Integrated Care System where he is leading the development of the systemwide digital and data strategy.
James E.K. Hildreth is the twelfth president and CEO of Meharry Medical College, the nation’s largest private, independent historically black academic health sciences center. He obtained a BA in chemistry from Harvard University and was selected as the first African-American Rhodes Scholar from Arkansas. He obtained a PhD in immunology from Oxford University where his studies focused on the biology of virus-specific cytotoxic T cells. James also became an expert in monoclonal antibody technology and cell adhesion molecules while at Oxford. He obtained an MD from Johns Hopkins University School of Medicine and took a leave of absence from medical school for a postdoctoral fellowship in pharmacology at Johns Hopkins.
In 1987, James joined the Johns Hopkins School of faculty as assistant professor. He was appointed as the first associate dean for graduate studies at Johns Hopkins in 1994. In 2002, he became the first African American in the 125-year history of Johns Hopkins School of Medicine to earn full professorship with tenure in basic sciences. In July 2005, James became director of the NIH-funded Center for AIDS Health Disparities Research at Meharry Medical College. In August of 2011, James became dean of the College of Biological Sciences at University of California, Davis. He was the first African-American dean in the university, which was founded in 1905. He was also appointed as a tenured professor in the Department of Cellular and Molecular Biology as well as professor in the Department of Internal Medicine in the UC Davis School of Medicine.
James’ research in immunology and virology, with a focus on HIV, has resulted in more than 130 publications in top journals and 11 patents. He has received numerous NIH grants to support his research including a prestigious NIH Director’s Pioneer Award. A technology he developed was licensed by Genentech as the basis for the FDA-approved drug Raptiva.
James received numerous awards for his research, commitment to diversity in medicine, biomedical research, and service to communities. His recognitions include honorary degrees, induction into the Arkansas Black Hall of Fame, the Johns Hopkins University Society of Scholars, and the Institute of Medicine (now the National Academy of Medicine), part of the National Academy of Sciences. He was recently named Nashvillian of the Year by Nashville Scene magazine for his leadership in the COVID-19 pandemic response and one the Fifty Most Influential Clinical Leaders by Modern Healthcare.
James has been appointed to two FDA advisory committees: Vaccines and Related Biological Products Advisory Committee (VRBPAC) and Antimicrobial Drugs Advisory Committee (AMDAC). These panels review COVID-19 vaccines and drugs respectively for approval. In February of 2021, he was appointed by President Joe Biden to the COVID-19 Health Equity Task Force. He has served on numerous national advisory boards including the Harvard University Board of Overseers. He currently serves on the Advisory Council to the NIH Director, as chair of the Veteran’s Administration National Academic Affiliations Council, and the board of directors of the Association of Academic Health Centers. James also serves on several other boards including chair of the board of the St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences.
Dr. Jim Kublin is an acclaimed global health expert who works on the development of vaccines and treatments for life-threatening infectious diseases including HIV, tuberculosis, malaria, and COVID-19. As executive director of the HIV Vaccine Trials Network (HVTN) at Fred Hutchinson Cancer Center (Fred Hutch), he coordinates its massive international efforts to test candidate vaccines. He plays a similar role for the COVID-19 Prevention Network, which since July 2020 has been managing large-scale testing of vaccines against SARS-CoV-2. His interest in global health was sparked when he was a 20-year-old volunteer working on malaria eradication in Nicaragua, where he contracted the disease himself. He became a doctor just as HIV/AIDS was emerging in American cities. Jim has carried out extensive research in malaria and HIV in South America, Southeast Asia, and Africa. In his role as medical director of the Seattle Malaria Clinical Trials Center, Jim continues to oversee studies on new malaria drugs and vaccines. At Fred Hutch, his team in the Kublin Lab conducts preclinical studies of the effects of the microbiome on vaccines, focusing on how responses of the immune system are changed by interactions with specific microbes that live naturally in the gut of humans and animals. He is also a clinical professor of Global Health at the University of Washington.
Jim earned his MD from Georgetown University School of Medicine in 1988 and his MPH from Johns Hopkins School of Public Health in 1997. He joined Fred Hutch in 2004.
Tony Ambrozie is senior vice president and chief digital officer/CIO for Baptist Health South Florida, the largest not-for-profit healthcare organization in South Florida. He is responsible for all technologies and customer experience as well as clinical digital and data transformation efforts.
Before joining Baptist Health, Tony served as senior vice president of technology and digital at The Walt Disney Company. In this role, he was responsible for a number of digital and core systems and technologies, engineering, and data analytics and machine learning for Disney parks, consumer products, games, and publishing.
Prior to joining Disney in 2013, Tony was vice president for digital platform technologies at American Express, where he was responsible for platform engineering, shared services development, and application security, with previous roles focused on application architecture, development, engineering, and performance.
Although he spent the past two decades focused on large business operations, Tony launched his technology career as the cofounder of a software development startup, specializing in building unique, small business applications.
Tony is a proven leader in the technology and digital space with a keen focus on using technology and data to enhance the consumer experience. He holds a dual MBA and master’s degree in information management from the W.P. Carey School of Business at Arizona State University.